Measure 109 and Psilocybin Services: What Therapists Need to Know  

October 27, 2023 | 9:00am-12:15pm Pacific Time

w/ Jason Luoma, PhD and Brian Pilecki, PhD 

Buy a Ticket

About The Workshop

Oregon's Psilocybin Services (voted in via Measure 109) are now open to the public and thousands of people per year will soon be seeking these services for relief from mental health problems. In addition, many more are already seeking treatment in the underground. All therapists in Oregon will soon be working with clients who are seeking or have sought psilocybin experiences for mental health and other reasons. Thus, it is imperative that all who work in mental health care in Oregon are familiar with at least the basics of how psilocybin works, how to help clients make good decisions about whether to utilize these services, and how to talk to them after they have received services. This workshop will orient therapists to the overall structure of psilocybin services in Oregon and describe how it is comprised of various parts such as service centers, facilitators, and growers. Presenters will identify similarities and differences between psilocybin services and the model of psilocybin-assisted therapy that has emerged in recent clinical trials. Harm reduction approaches will be used to identify how to talk to clients about their decisions to use psilocybin and how to provide therapeutic support before and after a psilocybin session. Workshop participants will be better informed as to the potential risks and benefits of psilocybin use, as well as in having conversations with clients who are considering accessing psilocybin services. 

About the presenters: These presenters have been intimately involved with the Measure 109 program since the start. Dr. Luoma was featured in the very first commercial ever aired in support of the Measure 109 program and both have served on committees as part of the rule making progress. Dr. Pilecki is a trainer for one of the largest psychedelic training organizations in the world where he is involved in training psilocybin facilitators. Dr. Luoma was co-founder of OPEN, a research collaborative at OHSU organized to evaluate the quality and equity of services delivered under measure 109. Both have been therapists and researchers in clinical trials related to MDMA-assisted therapy, trained hundreds of therapists in psychedelic-assisted therapy, and led psychedelic retreats in legal contexts. They are also experts in the utilization of harm reduction techniques around working with psychedelics in legal, aboveground practice, and have written multiple papers about the legal and ethical issues involved in the practice of psychedelic-assisted therapy.   

Meet Your Instructors

Jason Luoma, PhD

Jason  Luoma, CEO of Portland Psychotherapy in Portland, OR. His research focuses on shame, self-stigma, connection, and the application of ACT and psychedelic assisted therapy as an intervention shame and increasing self-compassion. He is currently principal investigator of a clinical of MDMA-assisted psychotherapy for social anxiety disorder that is one of the first trials of psychedelic assisted therapy in the Pacific Northwest. He also co-cofounded the Oregon Psilocybin Evaluation Nexus (OPEN) a practice-research collaborative headed at Oregon Health Sciences University. He also organized a special section on psychedelic assisted therapy and contextual behavioral science. He is also an internationally recognized trainer in ACT, former chair of the ACT training committee, and past president of the Association for Contextual Behavioral Science. He has over 70 publications including co-authoring two books:Learning Acceptance and Commitment TherapyandValues in Therapy: A Clinician’s Guide to Helping Clients Explore Values, Increase Psychological Flexibility, and Live a More Meaningful Life. His work on shame and compassion can be read at

Brian Pilecki, Ph.D.

Dr. Brian Pilecki is a clinical psychologist at the Portland Psychotherapy Clinic that specializes in the treatment of anxiety disorders (OCD, generalized anxiety, social anxiety, panic disorder), trauma and PTSD, and matters related to the use of psychedelics.  He completed a post-doctoral fellowship at The Warren Alpert Medical School of Brown University and practices from an orientation based in Acceptance and Commitment Therapy (ACT)He is an active researcher and has published on topics such as anxiety disorders, mindfulness, and psychedelics. At Portland Psychotherapy, Brian is a study therapist on a clinical trial investigating the use of MDMA-assisted therapy for the treatment of social anxiety disorder and understanding processes of change in how this novel form of treatment might work. He has given numerous workshops on topics related to psychedelics and served as a consultant for the Oregon Health Authority in helping to design a program for psilocybin services in the state of Oregon. Brian is also the author of the book ACT-Informed Exposure for Anxiety and co-host of Altered States of Context, a podcast about psychotherapy and psychedelics. 

Join us!



for up-and-coming professionals

  • Access to exclusive webinar setting with Jason Luoma, PhD and Brian Pilecki, PhD
  • Free Access to Portland Psychotherapy Community Resources
  • Must be enrolled in accredited study program

Professionals (w/ CE Certificate)


Most Popular

  • Access to exclusive webinar setting with Jason Luoma, PhD, Brian Pilecki, PhD
  • Continuing Education Certificate (3 credits)
  • Free Access to Portland Psychotherapy Community Resources



The workshop is for mental health care professionals who are new to Oregon’s Psilocybin Services, as well as those interested in learning how to incorporate client usage of psilocybin or other psychedelics into standard psychotherapy.  


After attending this training, participants will be able to:

  1. Participants will be able to describe the basic structure of Oregon’s Psilocybin Services. 
  2. Participants will be able to summarize research findings on psilocybin-assisted therapy and identify risks and benefits of psilocybin usage.  
  3. Participants will be able to describe how to use a harm reduction approach in preparation and integration of psilocybin experiences.  


Registration is online. Presentations will be recorded and sent to anyone who registers for the event. 


We reserve a number of partial scholarships for potential attendees who could not otherwise afford to come. We give particular priority given to those who would add diverse and under represented voices to our field. To submit an application, please click here.


Portland Psychology Clinic, Research & Training Center is approved by the American Psychological Association (APA) to sponsor continuing education for psychologists. Portland Psychotherapy, Clinic, Research & Training Center maintains responsibility for all programs and content.

This workshop grants 3 CE credits for therapists with the purchase of Professionals with CE Certificate ticket and live attendance of the entire workshop. Credit will not be given for only watching the recording.

REFUNDS/CANCELLATIONS: We charge a $15 administration fee for cancellations made by participants more than two weeks before the training event. For cancellations within two weeks of the training event, we will refund 50% of the tuition. Alternately, participants may elect to apply 100% of their tuition to a future training event. No refunds will be given after training events.

SPECIAL ACCOMODATIONS: Please contact us if you need accommodations to enable you to fully participate in the workshop. We will work with you and do our best to find a way to ensure your participation.

Buy a Ticket